CONMED Corporation with ticker code (CNMD) now have 7 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between 135 and 119 suggesting an average Analsyt target price of $126.14. Now with the previous closing price of $118.96 this would indicate that there is a potential upside of 6.0%. It’s also worth noting that there is a 50 day moving average of $110.54 while the 200 day moving average is $95.00. The total market capitalization for the company now stands at 3.68B. The stock price is currently at: 120.5 USD
The potential market cap would be $3,906,696,174 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 36.25 and a 2.42% return on assets.
